Zinner M J, Yeo C J, Jaffe B M
Ann Surg. 1984 Feb;199(2):197-204. doi: 10.1097/00000658-198402000-00012.
Serotonin and substance P circulate in high concentrations in patients with the carcinoid syndrome. These studies were performed to evaluate the effects of intravenous infusions of serotonin and substance P to reproduce carcinoid levels of these agents on central hemodynamics, regional blood flow (using the radioactive microsphere technique), and endogenous hormone release. Serotonin did not affect mean arterial pressure but it significantly increased cardiac output, decreased systematic vascular resistance, and redistributed regional blood flow, increasing blood flow to the heart, adrenals, fundus, and antrum. Substance P significantly decreased mean arterial pressure and systemic vascular resistance, increased cardiac output, and increased blood flow to adrenal, fundus, antrum, liver, and all muscular layers of the stomach and small bowel. Neither serotonin nor substance P affected skin blood flow, nor altered circulating levels of glucose, insulin, or gastrin. Although both of these agents seem to participate in the pathogenesis of the carcinoid syndrome, our studies suggest that it is not possible to ascribe all the hemodynamic abnormalities to either.
在类癌综合征患者中,血清素和P物质以高浓度循环。进行这些研究是为了评估静脉输注血清素和P物质以再现这些物质的类癌水平对中心血流动力学、局部血流(使用放射性微球技术)和内源性激素释放的影响。血清素不影响平均动脉压,但它显著增加心输出量,降低体循环血管阻力,并重新分配局部血流,增加流向心脏、肾上腺、胃底和胃窦的血流。P物质显著降低平均动脉压和体循环血管阻力,增加心输出量,并增加流向肾上腺、胃底、胃窦、肝脏以及胃和小肠所有肌层的血流。血清素和P物质均不影响皮肤血流,也不改变葡萄糖、胰岛素或胃泌素的循环水平。尽管这两种物质似乎都参与类癌综合征的发病机制,但我们的研究表明,不可能将所有血流动力学异常都归因于其中任何一种物质。